Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Septerna (SEPN), which is developing a treatment for hypoparathyroidism, has filed for a proposed $100M initial public ...

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...

Brampton's mayor says Ontario should change its Mental Health Act to allow forcible treatment in extreme addictions and ...

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

Rapamycin could counteract the harmful effects of Sodium Valproate, a common epilepsy medication, on fetal spinal cord development.

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Using patient-derived tumor organoids, researchers have identified which therapies may be most effective for individual sarcoma patients.

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...